Karkus Ted William 4
4 · ProPhase Labs, Inc. · Filed May 25, 2022
Insider Transaction Report
Form 4
Karkus Ted William
10% Owner
Transactions
- Exercise/Conversion
Common Stock, par value $0.005
2022-05-23$2.00/sh+450,000$900,000→ 2,783,471 total - Exercise/Conversion
Option (right to buy)
2022-05-23−450,000→ 0 totalExercise: $2.00Exp: 2024-04-27→ Common Stock (450,000 underlying) - Tax Payment
Common Stock, par value $0.005
2022-05-23$8.47/sh−278,257$2,356,837→ 2,505,214 total
Holdings
- 100,000(indirect: By Son)
Common Stock, par value $0.005
Footnotes (2)
- [F1]On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes.
- [F2]The option vested in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.